Ledger.Open graph →

SEC Form D · filed July 13, 2015

Recro Pharma, Inc

Offering

$16.0M

Sold

$16.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

MALVERN, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Gerri A. Henwood · Malvern, PAExec · Director Winston J. Churchill · Malvern, PADirector Michael L. Berelowitz · Malvern, PADirector Benjamin Willis · Seattle, WAExec · Director William L. Ashton · Malvern, PADirector Abraham J. Ludomirski · Malvern, PADirector Alfred A. Altomari · Malvern, PADirector Donna A. Nichols · Malvern, PAExec Charles A. Garner · Malvern, PAExec Wayne B. Weisman · Malvern, PADirector Steve L. Haupt · Rochester, NYExec · Director Winston J. Churchill · Malvern, PADirector William L. Ashton · Malvern, PADirector Abraham J. Ludomirski · Malvern, PADirector Alfred A. Altomari · Malvern, PADirector Michael L. Berelowitz · Malvern, PADirector Donna A. Nichols · Malvern, PAExec Charles A. Garner · Malvern, PAExec Wayne B. Weisman · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗